Quest Diagnostics Inc (DGX) Stock Price, Quote & News

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 973 520 2700

Website: www.questdiagnostics.com

Address:

500 Plaza Drive, Secaucus, United States

OfficialStocktwitsUser Dec. 26 at 11:50 PM

$DGX RSI: 32.65, MACD: -2.2977 Vol: 3.74, MA20: 180.36, MA50: 182.50 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Dec. 24 at 2:01 PM

$DGX poised for more gains? 🚀 With a Zacks Rank #2, DGX is up 14.2% over the past year, outpacing its industry. Strategic acquisitions and growth in Advanced Diagnostics across areas like cardiometabolic and autoimmune disease testing are key drivers to watch. 📈 Discover the full potential here 👉 https://www.zacks.com/stock/news/2808431/is-quest-diagnostics-stock-a-right-pick-for-your-portfolio-now?cid=sm-stocktwits-2-2808431-body-26162&ADID=SYND_STOCKTWITS_TWEET_2_2808431_BODY_26162

0 · Reply

ZacksResearch Dec. 24 at 12:42 PM

$DGX making its next move — growth isn’t coming from one place ⚖️ The company is leaning on acquisitions, advanced diagnostics, and strict cost discipline to drive performance, even as higher debt levels and broader macro pressures remain real risks to watch. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2808431/is-quest-diagnostics-stock-a-right-pick-for-your-portfolio-now?cid=sm-stocktwits-2-2808431-teaser-26124&ADID=SYND_STOCKTWITS_TWEET_2_2808431_TEASER_26124

0 · Reply

gaineous Dec. 23 at 7:14 PM

$DOCU $YOU $ZM $AMT $DGX & BITX

0 · Reply

Estimize Dec. 15 at 1:03 PM

Wall St is expecting 2.36 EPS for $DGX Q4 [Reporting 01/29 BMO] http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_cont

0 · Reply

gaineous Dec. 12 at 2:58 PM

$ONDS $DGX $AMT $ODD $YOU already know!

0 · Reply

OfficialStocktwitsUser Dec. 12 at 2:17 PM

$DGX RSI: 37.54, MACD: -0.7871 Vol: 3.83, MA20: 185.54, MA50: 183.33 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BEGUIN Dec. 10 at 3:06 PM

$NVDA Moat and ecosystem The CUDA ecosystem (18+ years of tools and libraries) and Nvidia’s networking stack make switching away from its platform costly and complex for large customers. New software and services layers ($DGX Cloud, NIMs, microservices) mean Nvidia is capturing more of the AI value chain over time. This combination of IP, software integration and recurring-like demand is closer to a “platform” profile than a commodity chip vendor, which supports a higher-than-market multiple

0 · Reply

TradeInYourJob Dec. 6 at 6:37 PM

$DGX Sell signal triggered on the monthly timeframe CCI.

0 · Reply

BillionerOfKing Dec. 3 at 3:04 AM

$DGX Current Stock Price: $182.42 Contracts to trade: $180 DGX Dec 19 2025 Call Entry: $4.80 Exit: $7.55 ROI: 57% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference

Dec 9, 2025, 11:17 AM EST - 26 days ago

Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

DGXX

Dec 2, 2025, 5:03 PM EST - 4 weeks ago

Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 1, 2025, 8:30 AM EST - 4 weeks ago

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States

Nov 14, 2025, 1:11 PM EST - 7 weeks ago

Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript

Nov 14, 2025, 10:31 AM EST - 7 weeks ago

Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

DGXX

Nov 12, 2025, 12:15 PM EST - 7 weeks ago

Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac

ADP ADC AFL GPI

Nov 11, 2025, 4:22 PM EST - 7 weeks ago

Quest Diagnostics Declares Quarterly Cash Dividend

Nov 3, 2025, 4:09 PM EST - 2 months ago

Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference

Oct 27, 2025, 7:45 AM EDT - 2 months ago

New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis

Oct 22, 2025, 3:10 PM EDT - 2 months ago

Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead

Oct 22, 2025, 1:19 PM EDT - 2 months ago

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings

Oct 21, 2025, 11:54 AM EDT - 2 months ago

Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 7:16 AM EDT - 2 months ago

Quest Diagnostics raises annual profit and revenue forecasts on lab test demand

Oct 21, 2025, 6:45 AM EDT - 2 months ago

Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Oct 6, 2025, 12:49 AM EDT - 3 months ago

Quest Diagnostics: Investing In Healthcare's Future Today

Sep 29, 2025, 7:07 PM EDT - 3 months ago

Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript

Sep 25, 2025, 10:00 AM EDT - 3 months ago

Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025

Sep 24, 2025, 8:05 AM EDT - 3 months ago

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Sep 23, 2025, 7:07 AM EDT - 3 months ago

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Sep 22, 2025, 8:07 AM EDT - 3 months ago

Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer

Sep 18, 2025, 9:00 AM EDT - 3 months ago

WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App

Sep 15, 2025, 6:21 PM EDT - 3 months ago

Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference

Sep 10, 2025, 1:16 PM EDT - 4 months ago

Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 9:32 AM EDT - 4 months ago

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Sep 2, 2025, 6:27 AM EDT - 4 months ago

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Aug 26, 2025, 9:00 AM EDT - 4 months ago

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

Aug 25, 2025, 8:52 AM EDT - 4 months ago

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Aug 15, 2025, 6:14 PM EDT - 5 months ago

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Aug 7, 2025, 9:08 AM EDT - 5 months ago

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Aug 5, 2025, 8:33 AM EDT - 5 months ago

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Jul 29, 2025, 8:52 AM EDT - 5 months ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Jul 22, 2025, 1:10 PM EDT - 5 months ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 12:22 PM EDT - 5 months ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 7:17 AM EDT - 5 months ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 6:47 AM EDT - 5 months ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 15, 2025, 7:57 AM EDT - 6 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:36 AM EDT - 6 months ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 9, 2025, 8:24 AM EDT - 6 months ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jun 25, 2025, 9:07 AM EDT - 6 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 23, 2025, 10:52 AM EDT - 6 months ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 10, 2025, 8:03 AM EDT - 7 months ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

May 20, 2025, 8:52 AM EDT - 8 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 16, 2025, 1:11 PM EDT - 8 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 6:03 AM EDT - 8 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 3, 2025, 4:26 AM EDT - 8 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

Apr 23, 2025, 1:17 PM EDT - 9 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 22, 2025, 12:09 PM EDT - 9 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 11:39 AM EDT - 9 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 7:37 AM EDT - 9 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

OfficialStocktwitsUser Dec. 26 at 11:50 PM

0 · Reply

ZacksResearch Dec. 24 at 2:01 PM

0 · Reply

ZacksResearch Dec. 24 at 12:42 PM

0 · Reply

gaineous Dec. 23 at 7:14 PM

$DOCU $YOU $ZM $AMT $DGX & BITX

0 · Reply

Estimize Dec. 15 at 1:03 PM

Wall St is expecting 2.36 EPS for $DGX Q4 [Reporting 01/29 BMO] http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_cont

0 · Reply

gaineous Dec. 12 at 2:58 PM

$ONDS $DGX $AMT $ODD $YOU already know!

0 · Reply

OfficialStocktwitsUser Dec. 12 at 2:17 PM

0 · Reply

BEGUIN Dec. 10 at 3:06 PM

0 · Reply

TradeInYourJob Dec. 6 at 6:37 PM

$DGX Sell signal triggered on the monthly timeframe CCI.

0 · Reply

BillionerOfKing Dec. 3 at 3:04 AM

0 · Reply

Trade2Win2019 Nov. 24 at 11:21 PM

$DGX good short idea right here 🐻📉📉📉🩸

0 · Reply

OfficialStocktwitsUser Nov. 24 at 2:57 PM

$DGX RSI: 74.20, MACD: 2.0364 Vol: 5.47, MA20: 182.87, MA50: 183.42 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Nov. 24 at 2:13 PM

$DGX up 17.8% in a year against industry’s 0.1% decline — can the rally continue? 📈 Quest Diagnostics’ strategic acquisitions and investments in advanced diagnostics are driving growth, with an earnings yield above industry average and an average earnings surprise of 2.5% 🔍. However, rising debt and stiff competition pose challenges ⚠️. Discover what could impact DGX's performance next 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-body-22185&ADID=SYND_STOCKTWITS_TWEET_2_2794563_BODY_22185

0 · Reply

ZacksResearch Nov. 24 at 1:13 PM

Is $DGX still worth holding while the pressure builds? The company is driving growth through acquisitions and advanced diagnostics, but rising debt and tough competition are weighing on its outlook — a real mixed setup for investors. Full risk/reward rundown here 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-teaser-22183&ADID=SYND_STOCKTWITS_TWEET_2_2794563_TEASER_22183

0 · Reply

SPYmyQQQ Nov. 21 at 7:32 PM

🎯 Target Hit 🏁 📨 From Nov 11, 2025 🏛️ $DGX 💵 Entry: $188.8800 ✅ Exit: $193.4320 💰 P/L: +2.41% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

gaineous Nov. 19 at 3:46 PM

Bullish for 2026 Complete Conviction $AMT $ODD $ONDS $YOU $DGX Above Ave Conviction ATEC DOCU ZM Forever Holds AXP EXPE WMT UBER *EQIX interesting; seems undervalued at first glance.

0 · Reply

notreload_ai Nov. 13 at 5:09 PM

$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/

0 · Reply

NVDAMillionaire Nov. 3 at 6:46 PM

$DGX Outstanding article that hits the mark on DGX's current state. So if you want to refresh your DGX insights or learn about DGX from scratch, this is a must read. https://beyondspx.com/quote/DGX/analysis/quest-diagnostics-accelerating-growth-with-advanced-diagnostics-and-strategic-market-capture-dgx

0 · Reply

Halo202 Nov. 2 at 9:47 PM

$DGX $180+ by Friday

0 · Reply

OfficialStocktwitsUser Oct. 31 at 12:17 PM

$DGX RSI: 36.45, MACD: -1.2211 Vol: 4.17, MA20: 182.43, MA50: 182.13 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Oct. 31 at 11:53 AM

$DGX Share Price: $175.84 Contract Selected: Feb 20, 2026 $175 Calls Buy Zone: $7.61 – $9.40 Target Zone: $12.22 – $14.94 Potential Upside: 52% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

prismmarketview Oct. 27 at 6:38 PM

(NYSE: $DGX) Quest Diagnostics reported its AD-Detect Alzheimer’s blood tests show 91% sensitivity and specificity, matching more invasive methods for identifying brain markers. https://prismmarketview.com/quest-diagnostics-posts-strong-study-results-for-its-ad-detect-alzheimers-blood-tests/

0 · Reply

Market Cap	19.33B
Revenue (ttm)	9.87B
Net Income (ttm)	871.00M
EPS (ttm)	N/A
PE Ratio	17.96
Forward PE	16.74
Profit Margin	8.82%
Debt to Equity Ratio	0.78

Volume	683,100
Avg Vol	1,052,656
Day's Range	N/A - N/A
Shares Out	111.24M
Stochastic %K	34%
Beta	0.64
Analysts	Sell
Price Target	$199.47